Co-led by Moffitt Cancer Center the study found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to no aspirin users. It was also found that women who were heavy users of no aspirin no steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) over a long period of time had a higher risk of developing ovarian cancer. For this study Shelley Tworoger worked with researchers at Huntsman Cancer Institute and the Harvard T.H. Chan School of Public Health to analyze data from more than 200000 women